Marie-Paule Lebitasy

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Gérard Zalcman, Julien Mazières, J. Margery et al. · The Lancet · 2015 · 972 citations

Medicine, Oncology, Pharmacology +10

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

Élisabeth Quoix, Gérard Zalcman, Jean-Philippe Oster et al. · The Lancet · 2011 · 575 citations

Medicine, Geriatric Medicine, Oncology +10

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib

Marie Wislez, Martine Antoine, Laurence Baudrin et al. · Lung Cancer · 2009 · 88 citations

Medicine, Oncology, Pathology +14

Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC).

Élisabeth Quoix, J.P. Oster, V. Westeel et al. · Journal of Clinical Oncology · 2010 · 65 citations

Medicine, Oncology, Pharmacology +15

Specific Features of Non-small Cell Lung Cancer in Women: A Retrospective Study of 1738 Cases Diagnosed in Bas-Rhin between 1982 and 1997

J. Foeglé, Guy Hédelin, Marie-Paule Lebitasy et al. · Journal of Thoracic Oncology · 2007 · 52 citations · Full text

Medicine, Oncology, Pathology +10